Not just that SC although it would have been great to see the result had a large amount of sales not been wiped out by hurricanes in Florida and Texas AND a 'phasing' issue in MENA.
Either way it is what it is and every time I speak with people at the company they are very positive and very excited about the future.
We should still see solid growth month on month from Neo, VascuCel and CardioCel although the full release of 3D will be the real kicker.... The price at $5500 US converts to about $7500 Australian and if the company can get 100 centres using 10 patches a month that's $7 500 000 every month.... This might be awhile of although it is certainly a goal the company could realise in the medium term.
Readers should remember that CardioCel3D currently has no competitor aside from Cryolife who harvests their patches from cadavers. These patches have many issues including availability, ease of use and calcification. CardioCel3D should kill Cryolife's product on the free market.
Not just that SC although it would have been great to see the...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.25 |
Change
0.740(5.48%) |
Mkt cap ! $301.2M | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.25 | $13.35 | $309.6K | 22.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1150 | $14.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.25 | 314 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |